In Vivo Detection of Circulating Tumor Cells Predicts High-Risk Features in Patients with Bladder Cancer

Investigators validated the efficacy of in vivo detection of circulating tumor cells in bladder cancer (BC) patients. A total of 216 BC patients were enrolled in this study.